Comparison of Age-Related Macular Degeneration Treatments Trials 2: Introducing Comparative Effectiveness Research

被引：4
作者：
Miller, Joan W. [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Kal Vista Pharmaceut Ltd, Boston, MA USA
[2] Alcon Res Inst, Ft Worth, TX USA
[3] Genentech Roche, San Francisco, CA USA
[4] Bausch & Lomb, Rochester, NY USA
[5] Sunovion, Marlborough, MA USA
来源：
OPHTHALMOLOGY | 2020年 / 127卷 / 04期
关键词：
RANIBIZUMAB;
D O I：
10.1016/j.ophtha.2019.11.025
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：S133 / S134
页数：2
相关论文
共 9 条
  • [1] Avastin Doesn't Blind People, People Blind People
    Gonzalez, Serafin
    Rosenfeld, Philip J.
    Stewart, Michael W.
    Brown, Jennifer
    Murphy, Steven P.
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2012, 153 (02) : 196 - 203
  • [2] Guyer DR, 1997, ARCH OPHTHALMOL-CHIC, V115, P865
  • [3] Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration The Comparison of Age-Related Macular Degeneration Treatments Trials
    Maguire, Maureen G.
    Martin, Daniel F.
    Ying, Gui-shuang
    Jaffe, Glenn J.
    Daniel, Ebenezer
    Grunwald, Juan E.
    Toth, Cynthia A.
    Ferris, Frederick L., III
    Fine, Stuart L.
    [J]. OPHTHALMOLOGY, 2016, 123 (08) : 1751 - 1761
  • [4] Ranibizumab and Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration
    Martin, Daniel F.
    Maguire, Maureen G.
    Fine, Stuart L.
    Ying, Gui-shuang
    Jaffe, Glenn J.
    Grunwald, Juan E.
    Toth, Cynthia
    Redford, Maryann
    Ferris, Frederick L., III
    [J]. OPHTHALMOLOGY, 2012, 119 (07) : 1388 - 1398
  • [5] Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration The CATT Research Group
    Martin, Daniel F.
    Maguire, Maureen G.
    Ying, Gui-shuang
    Grunwald, Juan E.
    Fine, Stuart L.
    Jaffe, Glenn J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (20) : 1897 - 1908
  • [6] VEGF: From Discovery to Therapy: The Champalimaud Award Lecture
    Miller, Joan W.
    [J]. TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2016, 5 (02):
  • [7] Ranibizumab for neovascular age-related macular degeneration
    Rosenfeld, Philip J.
    Brown, David M.
    Heier, Jeffrey S.
    Boyer, David S.
    Kaiser, Peter K.
    Chung, Carol Y.
    Kim, Robert Y.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14) : 1419 - 1431
  • [8] U.S. FDA, 2018, 2018 COMP POL PRIOR
  • [9] U.S. Food and Drug Administration, COMP LAWS POL
1